Smith S I, Oyedeji K S, Goodluck H A, Fowora M A, Anomneze E, Lesi O A
Molecular Biology and Biotechnology Division, Nigerian Institute of Medical Research, PMB 2013, Yaba, Logos, Nigeria.
West Indian Med J. 2011 Jan;60(1):33-5.
This study was carried out to screen the use of Helicobacter pylori stool antigen (HpSA) tests for diagnosis and monitoring of H pylori in Nigeria.
Seven hundred and forty participants were enrolled after informed consent was obtained, while 83 came back for a post-eradication test. The stool samples were taken from the patients at endoscopy and tested for HpSA.
The proportion of patients that were positive at the pretest, 520 (70.3%) was significantly higher (Fisher's exact p = 0.001) than those positive at the post-test, 44 (53%). There was a significant difference (F = 4.106, p = 0.043) between the mean age of those that came for the pretest (40.0 +/- 14.5 years) and those that came for the post-test, 43.6 +/- 11.6 years. More males than females had the tendency to come back for a post-eradication test.
Although potential bias was introduced during this study, HpSA using monoclonal antibody could still be used for diagnosis and monitoring of H pylori in Nigeria.
本研究旨在筛查幽门螺杆菌粪便抗原(HpSA)检测在尼日利亚用于幽门螺杆菌诊断和监测的情况。
在获得知情同意后,招募了740名参与者,其中83人回来进行根除治疗后的检测。在内镜检查时从患者采集粪便样本并检测HpSA。
检测前呈阳性的患者比例为520人(70.3%),显著高于检测后呈阳性的患者比例44人(53%)(Fisher精确检验p = 0.001)。前来进行检测前的患者平均年龄(40.0±14.5岁)与前来进行检测后的患者平均年龄(43.6±11.6岁)之间存在显著差异(F = 4.106,p = 0.043)。回来进行根除治疗后检测的男性多于女性。
尽管本研究期间引入了潜在偏倚,但使用单克隆抗体的HpSA仍可用于尼日利亚幽门螺杆菌的诊断和监测。